S. Uchiyama

发表

Ryuzo Mase, Shinichiro Uchiyama, Mutsumi Iijima, 2015, Neuropsychobiology.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Posterior circulation ASPECTS on diffusion-weighted MRI can be a powerful marker for predicting functional outcome

S. Uchiyama, H. Tei, T. Usui, 2010, Journal of Neurology.

Ulcerated carotid plaques with ultrasonic echolucency are causatively associated with thromboembolic cerebrovascular events.

Shinichiro Uchiyama, Y. Shimizu, S. Uchiyama, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

S. Uchiyama, Takenori Yamaguchi, Y. Ikeda, 2011, Cerebrovascular Diseases.

ASPECTS-Region-Dependent Functional Outcomes after Endovascular Therapy in Patients with Cardioembolic Stroke.

S. Uchiyama, K. Toyoda, T. Hamasaki, 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Characterizing the normative profile of 18F-FDG PET brain imaging: Sex difference, aging effect, and cognitive reserve

Yaakov Stern, Yunglin Gazes, Hiroshi Yoshizawa, 2014, Psychiatry Research: Neuroimaging.

Cilostazol Research in Asia: Can it Be Applied to European and American Patients?

S. Kwon, S. Uchiyama, Jong S. Kim, 2015, International journal of stroke : official journal of the International Stroke Society.

Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke.

S. Uchiyama, M. Iwata, K. Maruyama, 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel

Kortaro Tanaka, K. Houkin, T. Tominaga, 2021, Stroke.

Antithrombotic and thrombolytic therapy for ischemic stroke

S. Uchiyama, M. Yamazaki, 2012 .

Clopidogrel Two Doses Comparative 1-Year Assessment of Safety and Efficacy (COMPASS) Study in Japanese Patients with Ischemic Stroke

S. Uchiyama, K. Minematsu, N. Tanahashi, 2012, Cerebrovascular Diseases.

The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two Phase III, multicenter, randomized clinical trials

Y. Fukuuchi, S. Uchiyama, Takenori Yamaguchi, 2009, Journal of Neurology.

A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients with Noncardioembolic Cerebral Infarction

T. Okudera, Y. Fukuuchi, Y. Shinohara, 2007, Cerebrovascular Diseases.

New Modalities and Aspects of Antiplatelet Therapy for Stroke Prevention

S. Uchiyama, M. Iwata, Tomomi Nakamura, 2006, Cerebrovascular Diseases.

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

M. Hori, S. Goto, S. Uchiyama, 2014, Hypertension Research.

Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica

Y. Shimizu, S. Uchiyama, K. Ota, 2013, Journal of Neuroimmunology.

Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis

Eric E. Smith, Deepak L. Bhatt, J. Douketis, 2011, Circulation.

[Prevention of and therapy for cerebral infarction in the aged].

S. Uchiyama, 2006, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation

S. Uchiyama, M. Koga, K. Toyoda, 2022, PloS one.

Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke

K. Kitagawa, S. Uchiyama, H. Hoshino, 2022, Neurology.

Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

Kortaro Tanaka, K. Houkin, T. Isomura, 2019, The Lancet Neurology.

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)

M. Ezura, S. Uchiyama, M. Matsumoto, 2013, Cerebrovascular Diseases Extra.

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial

H. Naritomi, S. Uchiyama, H. Hoshino, 2014, International journal of stroke : official journal of the International Stroke Society.

One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Antithrombotic Therapy Influences Location, Enlargement, and Mortality from Intracerebral Hemorrhage

K. Nagata, S. Uchiyama, T. Sakamoto, 2008, Cerebrovascular Diseases.

Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study

K. Nagata, S. Uchiyama, T. Sakamoto, 2008, Stroke.

Platelet Activity and Antiplatelet Therapy in Patients with Ischemic Stroke and Transient Ischemic Attack

S. Uchiyama, Tomomi Nakamura, M. Yamazaki, 2008 .

Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy: The Bleeding With Antithrombotic Therapy (BAT) Study

K. Nagata, S. Uchiyama, T. Sakamoto, 2010, Stroke.

Inhibitory Effects of Ifenprodil Tartrate on Platelet Aggregation as Measuerd by the Particle Counting Method Using Light Scattering and Shear-Induced Platelet Aggregometer

S. Uchiyama, Y. Ozaki, M. Iwata, 1999 .

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

K. Okumura, S. Uchiyama, Y. Koretsune, 2019, Cardiology and Therapy.

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation

W. Shimizu, T. Ikeda, H. Shimokawa, 2018, Heart and Vessels.

Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design

K. Houkin, S. Uchiyama, T. Osanai, 2018, International journal of stroke : official journal of the International Stroke Society.

Alterations of Platelet, Coagulation, and Fibrinolysis Markers in Patients with Acute Ischemic Stroke

S. Uchiyama, M. Iwata, M. Yamazaki, 1997, Seminars in thrombosis and hemostasis.

Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis

Tokyo, Kazumichi Yoshida, K. Kario, 2022, Hypertension Research.

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

S. Connolly, E. Themeles, G. Hankey, 2018, The New England journal of medicine.

Sex Differences in Management and Outcomes of Cardioembolic Stroke: Post HOC Analyses of the RELAXED Study.

S. Uchiyama, K. Toyoda, T. Hamasaki, 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

Deepak L. Bhatt, K. Shimada, P. Steg, 2009, Journal of the Neurological Sciences.

Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.

S. Connolly, S. Kasner, P. Amarenco, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Five‐Year Risk of Stroke after TIA or Minor Ischemic Stroke

E. Vicaut, J. Ferro, M. Hennerici, 2018, The New England journal of medicine.

Secondary Prevention of Occlusive Cerebrovascular Diseases : Medical Treatment

S. Uchiyama, 2002 .

Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.

S. Uchiyama, 2001, Internal medicine.

Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke)

K. Kitagawa, S. Uchiyama, H. Maruyama, 2018, Stroke.

Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: Analysis of data from the MEGA Study, a large randomized controlled trial

Y. Ohashi, N. Tajima, Haruo M D Nakamura, 2009, Journal of the Neurological Sciences.

Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan.

Deepak L. Bhatt, K. Shimada, S. Goto, 2007, Circulation journal : official journal of the Japanese Circulation Society.

TIA as Acute Cerebrovascular Syndrome

P. Amarenco, K. Wong, S. Uchiyama, 2013 .

Effect of Sarpogrelate, a 5-HT2A Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study

S. Uchiyama, Y. Ozaki, K. Nishimaru, 2007, Cerebrovascular Diseases.

Alterations of haemostatic markers in various subtypes and phases of stroke.

S. Uchiyama, S. Maruyama, M. Yamazaki, 1993, Blood Coagulation and Fibrinolysis.

Effgect of Sympathetic Activation Induced by Cold Pressor Test on Cerebral Hemodynamics

S. Uchiyama, M. Iwata, Y. Tsutsumi, 2000 .

3) Brain Disorder and Renal Function

S. Uchiyama, M. Iwata, K. Maruyama, 2008 .

Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of prostanoids.

H. Numminen, S. Uchiyama, M. Hillbom, 2000, Alcohol and alcoholism.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance.

K. Okumura, S. Uchiyama, Y. Koretsune, 2019, Journal of cardiology.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-Dabigatran Surveillance.

K. Okumura, S. Uchiyama, Y. Koretsune, 2019, Journal of cardiology.

CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study

K. Nagata, S. Uchiyama, T. Sakamoto, 2014, Hypertension Research.

Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment

T. Matsui, K. Murakami, Mototsugu Kato, 2014, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

M. Matsuzaki, A. Hirayama, T. Hiro, 2012, Circulation journal : official journal of the Japanese Circulation Society.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation Journal.

Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation.

S. Shimizu, S. Uchiyama, A. Kobayashi, 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Effects of daily aspirin on cancer incidence and mortality in the elderly Japanese

K. Shimada, N. Ishizuka, S. Uchiyama, 2018, Research and practice in thrombosis and haemostasis.

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2017, Journal of atherosclerosis and thrombosis.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study

S. Ibayashi, E. Mori, Y. Shinohara, 2015, EBioMedicine.

Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess the effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke

K. Kitagawa, S. Uchiyama, M. Matsumoto, 2018, Annals of clinical biochemistry.

Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis

Eric E. Smith, Deepak L. Bhatt, J. Douketis, 2011, Circulation.

Evaluation of the Effects of Probucol and Pravastatin on Intima-media Thickness by Carotid Ultrasonography

S. Uchiyama, M. Iwata, Y. Tsutsumi, 2000 .

Physiological parameters of cerebral small-vessel disease

K. Kitagawa, S. Uchiyama, M. Matsumoto, 2019, Neurosonology.

Diagnosis and Management of Moyamoya Disease

T. Kawamata, S. Uchiyama, T. Ishikawa, 2020, Case Reports in Neurology.

Association of Th1/Th2-Related Chemokine Receptors in Peripheral T Cells with Disease Activity in Patients with Multiple Sclerosis and Neuromyelitis Optica

Y. Shimizu, S. Uchiyama, Masaki Kobayashi, 2011, European Neurology.

Differences in Clinical Characteristics between Patients with Transient Ischemic Attack Whose Symptoms Do and Do Not Persist on Arrival.

K. Ogasawara, K. Iihara, S. Uchiyama, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

T. Ogihara, Y. Ouchi, K. Kario, 2009, Hypertension Research.

Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.

M. Hori, S. Goto, S. Uchiyama, 2014, Circulation journal : official journal of the Japanese Circulation Society.

[Dabigatran, a new oral anticoagulant].

S. Uchiyama, 2011, Brain and nerve = Shinkei kenkyu no shinpo.

Characterizing the normative pro ﬁ le of 18 F-FDG PET brain imaging: Sex difference, aging effect, and cognitive reserve $ Psychiatry Research: Neuroimaging

Y. Gazes, S. Uchiyama, Y. Stern, 2014 .

[Abnormalities on diffusion-weighted magnetic resonance imaging in patients with transient ischemic attack].

S. Uchiyama, M. Iwata, Tomomi Nakamura, 2003, Rinshō shinkeigaku Clinical neurology.

Effect of d-Indobufen on Platelet Function in Patients with Cerebrovascular Disease

S. Uchiyama, S. Maruyama, M. Yamazaki, 1994 .

Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy

K. Nagata, S. Uchiyama, T. Sakamoto, 2010 .

Pharmacoeconomic analysis of cilostazol for the secondary prevention of cerebral infarction.

S. Uchiyama, Makoto Kobayashi, Tadao Inoue, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment.

S. Uchiyama, 2011, Cardiovascular therapeutics.

Aims: To investigate the relative contribution of on-treatment low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) to the risk of recurrent stroke and transient ischemic attack (TIA) in patients with his-

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2019 .

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol.

K. Kitagawa, S. Uchiyama, M. Matsumoto, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Study of the difference in vasodilatation of the brachial artery between three types of cerebral infarction by the flow-mediated dilatation (FMD) method

M. Iijima, S. Uchiyama, M. Iwata, 2008 .

Identification of Suspected Ruptured Atherosclerotic Plaque in Acute Ischemic Stroke on (18)F-Sodium Fluoride Positron Emission Tomography-Computed Tomography.

S. Uchiyama, C. Kao, G. Hung, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Risk factors for small cortical infarction on diffusion-weighted magnetic resonance imaging in patients with acute ischemic stroke.

S. Uchiyama, M. Iwata, Chisako Yano, 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[Transient ischemic attack, a medical emergency].

S. Uchiyama, 2009, Brain and nerve = Shinkei kenkyu no shinpo.

Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source

L. Wong, C. Liou, S. Uchiyama, 2021, Stroke.

Significance of Nonfocal Symptoms in Patients With Transient Ischemic Attack.

K. Ogasawara, K. Iihara, S. Uchiyama, 2018, Stroke.

The concept of acute cerebrovascular syndrome.

S. Uchiyama, 2014, Frontiers of neurology and neuroscience.

Transient ischemic attack as acute cerebrovascular syndrome

S. Uchiyama, 2015 .

Odor Identification Function Differs between Vascular Parkinson ismand Akinetic-Type Parkinson's Disease

K. Kitagawa, M. Iijima, M. Osawa, 2016 .

Ticlopidine Review of its Pharmacology, Clinical Efficacy and Tolerability in the Prevention of Cerebral Ischaemia and Stroke

G. Albers, M. Gent, H. Tohgi, 1996 .

[Antiplatelet therapy].

S. Uchiyama, 2006, Nihon rinsho. Japanese journal of clinical medicine.

Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke.

S. Uchiyama, S. Kuzuhara, A. Takahashi, 2003, Internal medicine.

Panel Discussion

H. Shigematsu, S. Uchiyama, Shinya Goto, 1997, Drugs.

Cerebrovascular disease and intracranial artery stenosis in patients with symptomatic peripheral artery disease.

N. Hasebe, S. Uchiyama, Takayuki Katayama, 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Incidence and Predictors of Ischemic Stroke Events during Hospitalization in Patients with Transient Ischemic Attack

K. Ogasawara, K. Iihara, S. Uchiyama, 2014, Cerebrovascular Diseases.

Intensive medical management of intracranial arterial stenosis

S. Uchiyama, 2020, The Lancet Neurology.

Comparison of the Efficacy and Safety of Oral Anticoagulants in East Asians With Atrial Fibrillation.

S. Uchiyama, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Factors Associated With Onset-to-Door Time in Patients With Transient Ischemic Attack Admitted to Stroke Centers

K. Ogasawara, K. Iihara, S. Uchiyama, 2014, Stroke.

Arterial Hypertension in Patients with Left Primary Hemifacial Spasm Is Associated with Neurovascular Compression of the Left Rostral Ventrolateral Medulla

M. Osawa, S. Uchiyama, M. Iwata, 2007, European Neurology.

Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study

E. Vicaut, J. Ferro, M. Hennerici, 2022, The Lancet Neurology.

Transient ischemic attack without self‐awareness of symptoms witnessed by bystanders: analysis of the PROMISE‐TIA registry

K. Ogasawara, K. Iihara, S. Uchiyama, 2020, European journal of neurology.

International multicenter cooperative observational study

K. Nagata, S. Uchiyama, K. Minematsu, 2010 .

Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.

S. Uchiyama, M. Yamazaki, K. Maruyama, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes

K. Kitagawa, S. Uchiyama, H. Maruyama, 2020, Journal of atherosclerosis and thrombosis.

Shear-induced platelet aggregation and its inhibition by antiplatelet agents in cerebral ischemia

S. Uchiyama, Y. Ikeda, M. Handa, 1993 .

Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia.

S. Uchiyama, S. Maruyama, I. Kobayashi, 1989, Stroke.

Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia

S. Uchiyama, S. Maruyama, M. Yamazaki, 1991, Lipids.

Correlation between symptomatic, radiological and etiological diagnosis in acute ischemic stroke

S. Uchiyama, K. Ohara, H. Tel, 1999, Acta neurologica Scandinavica.

Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program.

K. Okumura, S. Uchiyama, Y. Koretsune, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Primary stroke prevention by antithrombotic therapy

S. Uchiyama, 2009 .

Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2019, Stroke.

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event

K. Kitagawa, S. Uchiyama, H. Maruyama, 2017, Journal of atherosclerosis and thrombosis.

Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.

S. Uchiyama, M. Yamazaki, 2003, Stroke.

Alterations of Hemostatic Markers in Cardioembolic Stroke

S. Uchiyama, H. Tei, S. Maruyama, 1990 .

8. Large-scale Clinical Study of Antithrombotic Treatment for Stroke Prevention.

S. Uchiyama, 2010 .

[Internal medicine and neurological diseases: progress in diagnosis and treatment. Topics: IX. Neurological diseases related to hematological diseases: 1. Coagulopathy and stroke].

S. Uchiyama, 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

2. Antiphospholipid Syndrome (APS)

S. Uchiyama, Hiromi Terashi, 2010 .

Flow cytometric analysis of reticulated platelets in patients with ischemic stroke.

S. Uchiyama, Y. Takakuwa, M. Iwata, 2002, Thrombosis research.

New modalities for the treatment of acute cardioembolic stroke.

S. Uchiyama, 2006, Internal medicine.

RECURRENT EMBOLIC CEREBRAL INFARCTION; LONG-TERM ANTICOAGULANT AND ANTIPLATELET THERAPY

S. Uchiyama, S. Maruyama, I. Kobayashi, 1988 .

Clinical Characteristics of Stroke Patients with Antiphospholipid Antibodies

S. Uchiyama, M. Iwata, Y. Tsutsumi, 2005, Cerebrovascular Diseases.

Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.

S. Uchiyama, M. Iwata, Tomomi Nakamura, 2007, Thrombosis research.

Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke or Transient Ischemic Attack With Non-Valvular Atrial Fibrillation.

S. Uchiyama, K. Toyoda, T. Hamasaki, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis

Kortaro Tanaka, K. Houkin, T. Tominaga, 2021, Journal of the American Heart Association.

Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF.

M. Hori, S. Goto, S. Uchiyama, 2016, Journal of cardiology.

Shear-Induced Platelet Aggregation in Cerebral Ischemia platelet aggregation (SIPA) in patients with cerebral ischemia with a newly developed apparatus and studied

S. Uchiyama, M. Handa, S. Maruyama, 2005 .

Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan.

Y. Ikeda, S. Goto, S. Uchiyama, 2009, Journal of atherosclerosis and thrombosis.

Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents.

S. Uchiyama, M. Iwata, M. Yamazaki, 2005, Thrombosis research.

Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study

K. Ogasawara, K. Iihara, S. Uchiyama, 2015, Cerebrovascular Diseases Extra.

Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation : Analyses of a Multicenter Retrospective Study

K. Ogasawara, K. Iihara, S. Uchiyama, 2015 .

Cerebral Infarction

S. Uchiyama, 1961, Nature.

[Japanese guidelines for the management of stroke 2009].

Shinichiro Uchiyama, S. Uchiyama, 2011, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction.

S. Uchiyama, M. Iwata, M. Yamazaki, 2001, Thrombosis research.

Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.

S. Uchiyama, Y. Koretsune, M. Yasaka, 2022, Journal of cardiology.

P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study

M. Ezura, Haruko Yamamoto, S. Uchiyama, 2022, Journal of atherosclerosis and thrombosis.

USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE)

G. Lip, K. Kitagawa, S. Goto, 2012 .

Platelet activation and antiplatelet therapy in patients with ischemic stroke

S. Uchiyama, M. Iwata, Y. Tsutsumi, 2003 .

Effects of Dipyridamole and Aspirin on Shear-Induced Platelet Aggregation in Whole Blood and Platelet-Rich Plasma

S. Uchiyama, M. Iwata, M. Yamazaki, 2002, Cerebrovascular Diseases.

[Pathophysiology of carotid stenosis].

S. Uchiyama, M. Yamazaki, 2010, Brain and nerve = Shinkei kenkyu no shinpo.

Pallido-nigro-luysial atrophy with massive appearance of corpora amylacea in the CNS

S. Uchiyama, K. Kosaka, M. Matsushita, 2004, Acta Neuropathologica.

[Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation].

Y. Shimizu, S. Uchiyama, M. Iwata, 2010, Rinsho shinkeigaku = Clinical neurology.

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

K. Sugano, K. Shimada, N. Hiramatsu, 2011, Journal of gastroenterology.

Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology

Y. Shimizu, N. Shibata, S. Uchiyama, 2014, Journal of Neurology.

TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis

C. Duyckaerts, T. Uchihara, M. Iijima, 2015, Journal of neuropathology and experimental neurology.

The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): a nation-wide, prospective large cohort study; the study design.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Sporadic late-onset nemaline myopathy in a patient with primary Sjögren’s syndrome

Y. Shimizu, S. Uchiyama, M. Iwata, 2012, Journal of Neurology.

Measurement Conditions and Effects of Antiplatelet Agents on Fibrinogen Binding to Activated Platelets by Flow Cytometry

S. Uchiyama, M. Iwata, M. Yamazaki, 1997 .

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Y. Ohashi, Y. Shinohara, S. Uchiyama, 2010, The Lancet Neurology.

Edaravone (Radical Scavenger) versus Sodium Ozagrel (Antiplatelet Agent) in Acute Noncardioembolic Ischemic Stroke (EDO Trial)

Shotai Kobayashi, Y. Shinohara, S. Uchiyama, 2009, Cerebrovascular Diseases.

Activated microglia in ischemic stroke penumbra upregulate MCP‐1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes

K. Kitagawa, N. Shibata, S. Uchiyama, 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

Platelet function tests in thrombotic cerebrovascular disorders.

M. Osawa, S. Uchiyama, K. Hirosawa, 1983, Stroke.

Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study

K. Sugano, K. Shimada, S. Goto, 2011, Cardiovascular Drugs and Therapy.

Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials.

Y. Shinohara, S. Kwon, S. Goto, 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Evaluation of platelet function by filter bleeding time

S. Uchiyama, S. Maruyama, I. Kobayashi, 1985 .

Role of thromboxane A2 in thrombosis and hemostasis

S. Uchiyama, S. Maruyama, I. Kobayashi, 1987 .

Increased von Willebrand factor in acute stroke patients with atrial fibrillation.

K. Nagata, S. Uchiyama, A. Suzuki, 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[QuantiFERON: an early diagnostic tool for cerebral tuberculosis].

S. Uchiyama, M. Iwata, Y. Tsutsumi, 2008, Rinsho shinkeigaku = Clinical neurology.

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.

S. Uchiyama, H. Okamoto, K. Ohara, 2007, Internal medicine.

Charcot‐marie‐tooth disease type 4C in Japan: Report of a case

Y. Shimizu, Kayoko Saito, S. Uchiyama, 2013, Muscle & nerve.

Progress of antiplatelet therapy

S. Uchiyama, M. Yamazaki, 2014 .

Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation.

S. Ogawa, S. Uchiyama, M. Matsumoto, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance

K. Okumura, S. Uchiyama, Y. Koretsune, 2016, Journal of arrhythmia.

Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source　- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.

H. Diener, S. Uchiyama, K. Toyoda, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment.

M. Hori, S. Goto, S. Uchiyama, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.

M. Hori, S. Goto, S. Uchiyama, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

Kortaro Tanaka, S. Ibayashi, K. Nagata, 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial.

M. Hori, S. Goto, S. Uchiyama, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation

S. Uchiyama, Y. Koretsune, S. Cano, 2019, Journal of medical economics.

Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study

S. Uchiyama, Y. Koretsune, S. Cano, 2018, Current medical research and opinion.

Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis

W. Shimizu, T. Ikeda, H. Shimokawa, 2019, Heart and Vessels.

Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.

W. Shimizu, Y. Okumura, T. Ikeda, 2016, The Tohoku journal of experimental medicine.

[How to properly use warfarin and new anticoagulants].

S. Uchiyama, 2013, Rinsho shinkeigaku = Clinical neurology.

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.

Kiyoshi Yoshida, M. Hori, Hiroshi Sato, 2006, Stroke.

Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry.

K. Shimada, K. Kitagawa, S. Goto, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

The MG‐QOL15 Japanese version: Validation and associations with clinical factors

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2012, Muscle & nerve.

Topical naphazoline in the treatment of myasthenic blepharoptosis

Y. Shimizu, Shigeaki Suzuki, N. Suzuki, 2011, Muscle & nerve.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

R. Sacco, H. Diener, J. Ferro, 2019, The New England journal of medicine.

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

S. Connolly, E. Themeles, G. Hankey, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

J. Healey, S. Connolly, D. Gladstone, 2019, JAMA neurology.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Deepak L. Bhatt, R. D'Agostino, P. Wilson, 2008, American heart journal.

Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS

K. Kitagawa, S. Uchiyama, K. Toyoda, 2019, International journal of stroke : official journal of the International Stroke Society.

Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study

W. Shimizu, T. Ikeda, H. Shimokawa, 2021, Heart and Vessels.

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation

K. Kitagawa, M. Iijima, S. Uchiyama, 2017, Cerebrovascular Diseases Extra.

A Modified Essen Stroke Risk Score for Predicting Recurrent Cardiovascular Events: Development and Validation

Kortaro Tanaka, K. Houkin, S. Miyamoto, 2013, International journal of stroke : official journal of the International Stroke Society.

Aspirin for primary stroke prevention in elderly patients with vascular risk factors

S. Uchiyama, 2017, Journal of general and family medicine.

Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

J. Pogue, S. Connolly, E. Themeles, 2016, European stroke journal.

A case of adenoid cystic carcinoma presenting as Garcin's syndrome without mass formation.

Y. Shimizu, A. Hiroi, N. Shibata, 2012, Internal medicine.

Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2014, Clinical Neurology and Neurosurgery.

[A case of chorea gravidarum with moyamoya disease].

M. Osawa, S. Uchiyama, M. Iwata, 2000, Rinshō shinkeigaku Clinical neurology.

Platelets and Atherothrombosis: An Essential Role for Inflammation in Vascular Disease — A Review

Á. Avezum, S. Steinhubl, M. Sabatine, 2011 .

Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway

E. Nagata, S. Snyder, T. Morikawa, 2012, Proceedings of the National Academy of Sciences.

Shear‐Induced Platelet Aggregation in Cerebral Ischemia

S. Uchiyama, Y. Ikeda, M. Handa, 1994, Stroke.

Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis-comparison between Onuf’s neurons and other sacral motor neurons-

C. Duyckaerts, S. Kakei, T. Uchihara, 2014, Acta neuropathologica communications.

Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis-comparison between Onuf’s neurons and other sacral motor neurons-

C. Duyckaerts, S. Kakei, T. Uchihara, 2014, Acta Neuropathologica Communications.

Immunohistochemical Detection of 13(R)-hydroxyoctadecadienoic Acid in Atherosclerotic Plaques of Human Carotid Arteries Using a Novel Specific Antibody

T. Kawamata, N. Shibata, S. Uchiyama, 2009, Acta histochemica et cytochemica.

Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients

K. Kario, N. Yonemoto, K. Kitagawa, 2016, Thrombosis and Haemostasis.

Front & Back Matter

P. Amarenco, S. Uchiyama, K. Minematsu, 2014, European Neurology.

Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)

Y. Ohashi, N. Tajima, S. Uchiyama, 2008, Circulation.

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial

A. Terashi, Shotai Kobayashi, Y. Fukuuchi, 2008, Stroke.

Five-Year Prognosis After TIA or Minor Ischemic Stroke in Asian and Non-Asian Populations

E. Vicaut, J. Ferro, M. Hennerici, 2020, Neurology.

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials

P. Sandercock, B. Davis, G. Hankey, 2021, BMC Medical Research Methodology.

Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

Y. Ohashi, N. Tajima, S. Uchiyama, 2009, Hypertension.

Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.

Y. Ohashi, N. Tajima, S. Uchiyama, 2008, Atherosclerosis.

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study

Hideki Origasa, Toshifumi Hibi, Takashi Kawai, 2019, Heart and Vessels.

Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.

K. Kitagawa, Haruko Yamamoto, T. Miyata, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting

E. Vicaut, J. Ferro, M. Hennerici, 2017, Stroke.

Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: A pilot study

S. Uchiyama, Tomomi Nakamura, S. Tsuruta, 2012, Journal of the Neurological Sciences.

Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study

K. Sugano, K. Shimada, S. Goto, 2013, Journal of Gastroenterology.

Brain natriuretic peptide in acute ischemic stroke.

Shinichiro Uchiyama, Mutsumi Iijima, M. Iijima, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Features of patients with transient monocular blindness: a multicenter retrospective study in Japan.

K. Ogasawara, K. Iihara, S. Uchiyama, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Cardioembolic stroke is frequent in late recurrence after transient ischemic attack.

S. Shimizu, S. Uchiyama, T. Nagao, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Clinical features and functional outcome of stroke after transient ischemic attack.

S. Shimizu, S. Uchiyama, S. Mizuno, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial

K. Houkin, H. Naritomi, T. Tominaga, 2023, Stroke.

K. Shimada, S. Goto, S. Uchiyama, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Risk Factor Profile and Management of Cerebrovascular Patients in the REACH Registry

Deepak L. Bhatt, R. D'Agostino, P. Wilson, 2008, Cerebrovascular Diseases.

Prolonged QTc Interval Predicts Poststroke Paroxysmal Atrial Fibrillation

K. Kitagawa, S. Shimizu, S. Uchiyama, 2015, Stroke.

Slow Sinus Heart Rate as a Potential Predictive Factor of Paroxysmal Atrial Fibrillation in Stroke Patients

S. Shimizu, S. Uchiyama, T. Nagao, 2013, Cerebrovascular Diseases.

Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.org

E. Vicaut, J. Ferro, M. Hennerici, 2017, Stroke.

Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events

K. Nagata, P. Amarenco, K. Kitagawa, 2020, Journal of atherosclerosis and thrombosis.

Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project

K. Shimada, N. Ishizuka, S. Uchiyama, 2016, Stroke.

Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2

Y. Ohashi, Y. Shinohara, S. Uchiyama, 2014, Cerebrovascular Diseases.

One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry.

Kortaro Tanaka, K. Houkin, S. Miyamoto, 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Brachial-ankle pulse wave velocity is associated with 3-month functional prognosis after ischemic stroke.

K. Kitagawa, S. Shimizu, S. Uchiyama, 2016, Atherosclerosis.

The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.

W. Shimizu, Y. Okumura, T. Ikeda, 2018, International journal of cardiology.

The EXPAND study : Ef fi cacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fi brillation

W. Shimizu, Y. Okumura, T. Ikeda, 2018 .

Fibrinolytic Activity and Platelet Function in Subjects with Obstructive Sleep Apnoea and a Patent Foramen Ovale: Is There an Option for Prevention of Ischaemic Stroke?

S. Uchiyama, M. Hillbom, A. Riutta, 2012, Stroke research and treatment.

Leukocyte Filterability in Patients with Various Subtype of Cerebral Infarction and in vitro Effects of FMLP, PAF and PAF Antagonist

S. Uchiyama, M. Iwata, S. Maruyama, 1995 .

Symmetrical progressive intracranial calcification in a patient with SLE.

S. Uchiyama, M. Iwata, S. Hashimoto, 2010, Internal medicine.

Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2017, Journal of atherosclerosis and thrombosis.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2019, Journal of atherosclerosis and thrombosis.

Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness : The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2017 .

Deteriorating Ischemic Stroke in 4 Clinical Categories Classified by the Oxfordshire Community Stroke Project

S. Uchiyama, H. Tei, K. Ohara, 2000, Stroke.

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

K. Shimada, N. Ishizuka, S. Uchiyama, 2014, JAMA.

Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Thalia Shoshana Field, Eric E. Smith, S. Connolly, 2020, JAMA neurology.

Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke

A. Ogawa, K. Kitagawa, T. Kitazono, 2021, Stroke.

Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.

Y. Shimizu, S. Uchiyama, Y. Tsutsumi, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

A sensitive marker for left atrial dysfunction as a risk factor of cardioembolic stroke after cessation of paroxysmal atrial fibrillation.

S. Uchiyama, 2003, Internal medicine.

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke.

E. Vicaut, J. Ferro, M. Hennerici, 2016, The New England journal of medicine.

Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2017, Stroke.

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)

S. Ibayashi, E. Mori, Shotai Kobayashi, 2013, International journal of stroke : official journal of the International Stroke Society.

5) Cerebrovascular Disease

S. Uchiyama, 2009 .

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

[The MG-QOL15 Japanese version: validation and associations with clinical factors].

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2012, Rinsho shinkeigaku = Clinical neurology.

Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study

K. Fujihara, Y. Shimizu, Shigeaki Suzuki, 2011, BMJ Open.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)

K. Shimada, N. Ishizuka, S. Uchiyama, 2018, American Journal of Cardiovascular Drugs.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or OlderWith Atherosclerotic Risk Factors A Randomized Clinical Trial

K. Shimada, N. Ishizuka, S. Uchiyama, 2014 .

[Moebius syndrome associated with obesity, dwarfism, endocrinological abnormalities and various minor anomalies].

S. Uchiyama, S. Maruyama, Y. Takemura, 1986, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Supranuclear ophthalmoparesis and vacuolar degeneration of the cerebral white matter in amyotrophic lateral sclerosis: A clinicopathological study

T. Mizutani, T. Uchihara, A. Nakamura, 2012, Amyotrophic Lateral Sclerosis.

[A case of delayed radiation lumbo-sacral plexopathy].

S. Uchiyama, S. Maruyama, I. Kobayashi, 1990, No to shinkei = Brain and nerve.

Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack

K. Ogasawara, K. Iihara, S. Uchiyama, 2017, International journal of stroke : official journal of the International Stroke Society.

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)

A. Ogawa, K. Kitagawa, T. Kitazono, 2019, The Lancet Neurology.

Japanese Versus Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: Subanalysis of TIA registry.org.

K. Nagata, P. Amarenco, K. Kitagawa, 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study

K. Kitagawa, S. Uchiyama, H. Maruyama, 2020, Journal of atherosclerosis and thrombosis.

[Stroke in cancer patients].

S. Uchiyama, M. Iwata, Hiromi Terashi, 2008, Brain and nerve = Shinkei kenkyu no shinpo.

The relationship between the effect of pravastatin and risk factors for coronary heart disease in Japanese patients with hypercholesterolemia.

Y. Ohashi, N. Tajima, S. Uchiyama, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Comparison of parameters of 123I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features

S. Uchiyama, C. Kondo, M. Momose, 2011, Annals of nuclear medicine.

Examination timing and lesion patterns in diffusion-weighted magnetic resonance imaging of patients with classically defined transient ischemic attack.

K. Ogasawara, K. Iihara, S. Uchiyama, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Activation of the Non-receptor Tyrosine Kinase cSrc in Macrophage-rich Atherosclerotic Plaques of Human Carotid Arteries

N. Shibata, S. Uchiyama, Makio Kobayashi, 2007, Acta histochemica et cytochemica.

A Randomized Trial of E5510 versus Aspirin in Patients with Transient Ischemic Attacks

M. Fujishima, Y. Shinohara, H. Tohgi, 1995, Angiology.

Differences in odor identification among clinical subtypes of Parkinson’s disease

T. Kobayakawa, S. Saito, M. Iijima, 2011, European journal of neurology.

Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.

Y. Itoyama, K. Fujihara, T. Misu, 2011, The Tohoku journal of experimental medicine.

The pathology of fulminant neuromyelitis optica with extremely high level of serum anti aquaporin 4 antibody

Y. Shimizu, S. Uchiyama, Makio Kobayashi, 2011 .

Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease

T. Kobayakawa, S. Saito, M. Iijima, 2010, Movement disorders : official journal of the Movement Disorder Society.

Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson’s Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance

Hiroshi Mitoma, Shinichiro Uchiyama, Mutsumi Iijima, 2017, Front. Neurol..

Small vessel occlusion is a high-risk etiology for early recurrent stroke after transient ischemic attack

K. Ogasawara, K. Iihara, S. Uchiyama, 2019, International Journal of Stroke.

Ankle-brachial index and neurologic deterioration in acute ischemic stroke.

S. Uchiyama, K. Ishizuka, T. Hoshino, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are associated with 3-month functional outcome of stroke in patients with prior coronary artery disease.

S. Shimizu, S. Uchiyama, K. Ishizuka, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Transient neurological attack before vertebrobasilar stroke

S. Shimizu, S. Uchiyama, T. Nagao, 2013, Journal of the Neurological Sciences.

CHADS2 score predicts functional outcome of stroke in patients with a history of coronary artery disease

S. Shimizu, S. Uchiyama, K. Ishizuka, 2013, Journal of the Neurological Sciences.

Prevalence and Clinical Correlates of Poststroke Behavioral Dysexecutive Syndrome

V. Mok, W. Tang, O. Soo, 2019, Journal of the American Heart Association.

Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial

K. Kitagawa, S. Uchiyama, H. Hoshino, 2022, International journal of stroke : official journal of the International Stroke Society.

Effects of ethanol (beer) on blood coagulability, fibrinolytic activity, platelet aggregability, blood viscosity, and serum protein and lipids

M. Osawa, S. Uchiyama, S. Maruyama, 1983 .

[Recurrent cerebral infarction caused by chronic disseminated intravascular coagulation associated with ovarian cancer].

S. Uchiyama, K. Ota, S. Maruyama, 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial – PRASTRO-I trial

A. Ogawa, K. Kitagawa, T. Kitazono, 2018, Expert opinion on pharmacotherapy.

Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial

A. Ogawa, K. Kitagawa, T. Kitazono, 2020, Journal of atherosclerosis and thrombosis.

Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study

E. Vicaut, J. Ferro, M. Hennerici, 2023, The Lancet Neurology.

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation (sub-analysis of the expand study)

H. Shimokawa, T. Kitazono, S. Uchiyama, 2017, Journal of the Neurological Sciences.

Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF.

M. Hori, S. Goto, S. Uchiyama, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Rivaroxaban administration after acute ischemic stroke: The RELAXED study

S. Uchiyama, K. Toyoda, T. Hamasaki, 2019, PloS one.

Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.

K. Shimada, N. Ishizuka, N. Yamada, 2010, American heart journal.

Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks

K. Shimada, N. Ishizuka, S. Uchiyama, 2019, Journal of hypertension.

[Hemostatic abnormalities].

S. Uchiyama, M. Yamazaki, 2006, Nihon rinsho. Japanese journal of clinical medicine.

Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study.

T. Kitazono, S. Uchiyama, H. Origasa, 2023, International journal of cardiology.

Head injury.

S. Uchiyama, F. Coakley, R. Owen, 1996, Journal of neurology, neurosurgery, and psychiatry.

Predictors of good prognosis in total anterior circulation infarction within 6 h after onset under conventional therapy

S. Uchiyama, H. Tei, T. Usui, 2006, Acta neurologica Scandinavica.

Activation of the non-receptor tyrosine kinase cSrc in macrophage-rich atherosclerotic plaques of human carotid arteries.

N. Shibata, S. Uchiyama, Makio Kobayashi, 2007, Acta histochemica et cytochemica.

Differences in Endothelial Function between Ischemic Stroke Subtypes.

K. Kitagawa, M. Iijima, S. Uchiyama, 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Factors associated with the misdiagnosis of cerebellar infarction.

S. Shimizu, S. Uchiyama, H. Tei, 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review

K. Kitagawa, M. Iijima, M. Osawa, 2015, eNeurologicalSci.

Activated microglia in ischemic stroke penumbra upregulate MCP‐1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes

K. Kitagawa, N. Shibata, S. Uchiyama, 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial

A. Terashi, Shotai Kobayashi, Y. Fukuuchi, 2008, Stroke.

Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke.

S. Uchiyama, S. Kuzuhara, A. Takahashi, 2003, Internal medicine.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Deepak L. Bhatt, R. D'Agostino, E. Ohman, 2008, American heart journal.

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com

S. Uchiyama, H. Hoshino, K. Toyoda, 2022, Journal of atherosclerosis and thrombosis.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA

K. Kitagawa, T. Ohtsuki, S. Uchiyama, 2019 .

Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events.

P. Touboul, P. Amarenco, S. Uchiyama, 2023, JAMA neurology.

Characterizing the normative profile of 18F-FDG PET brain imaging: Sex difference, aging effect, and cognitive reserve

Y. Stern, Y. Gazes, S. Uchiyama, 2014, Psychiatry Research: Neuroimaging.

Cilostazol plus aspirin versus aspirin alone in patients with symptomatic intracranial arterial stenosis: Results of catharsis

M. Ezura, S. Uchiyama, M. Matsumoto, 2013, Journal of the Neurological Sciences.

Secondary prevention of vascular events by combination therapy with aspirin and dilazep in patients with cerebral infarction

S. Uchiyama, T. Mannen, S. Maruyama, 1992 .

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation

W. Shimizu, T. Ikeda, H. Shimokawa, 2018, Heart and Vessels.

Y. Ohashi, N. Tajima, S. Uchiyama, 2009, Hypertension.

Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF.

M. Hori, S. Goto, S. Uchiyama, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Prevention of recurrence and inhibition of platelet aggregation by antiplatelet therapy in ischemic cerebrovascular disease.

S. Uchiyama, S. Maruyama, Reiko Sato, 1992 .

Progressive ischemic stroke in the symptomatic subgroups of the Oxfordshire Community Stroke Project.

S. Uchiyama, H. Tei, K. Ohara, 1998 .

Assessment of smoking care by stroke specialists in patients with recent TIA and minor stroke: an international prospective registry-based cohort study

S. Uchiyama, Hugo Charles, Gregory W. Albers, 2024, BMJ open.